Edap Tms Sa ADR (EDAP)

$4.71 0.00 (N/A)
Market Cap 176.12M
Revenue (ttm) 69.38M
Net Income (ttm) -20.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.66%
Debt to Equity Ratio 0.26
Volume 58,300
Avg Vol 83,474
Day's Range N/A - N/A
Shares Out 37.39M
Stochastic %K 61%
Beta -0.16
Analysts Sell
Price Target $6.83

Company Profile

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology...

Industry: Medical Distribution
Sector: Healthcare
Phone: 33 4 72 15 31 50
Address:
Parc dActivites la Poudrette-Lamartine, 4/6, rue du DauphinE, Vaulx-En-Velin, France
finedge
finedge Feb. 23 at 3:28 PM
$EDAP Financial reporting has factored in 10 percent tariff prior and buyers have paid the additional cost. Sales continue to pace well and will result in the future earnings. Stay strong to the long term and as an opinionated guidance Hold and Buy for a strengthened inflection point targeted record highs. There is an HMO purchase in the horizon. Let’s go!
0 · Reply
finedge
finedge Feb. 23 at 2:54 PM
$EDAP snapped up at 4.40
0 · Reply
Georges8792
Georges8792 Feb. 23 at 7:10 AM
$EDAP https://www.linkedin.com/posts/nirav-bhatt-76b7b521_endometriosis-hifu-focalone-activity-7430864360937291776-HqGV?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
mikegrand
mikegrand Feb. 23 at 3:36 AM
$EDAP https://youtu.be/DObcQVY4s5w?si=LTlNMNzzvR_d1t4l Interesting discussion in focal therapy, he mentions all the ongoing trials with HIFU and mentions the HIFUSA trial. I mentioned this trial awhile ago cause I was wanting an update and it seems it ends in June of this year and the preliminary results look good as it shows people that have HIFU early on instead of active surveillance have a 50% better chance of avoiding radical treatments down the line while still maintaining QoL That would be big if focal therapy takes place of active surveillance as a first line measure against most early cancers if you can avoid radical treatments downstream and would look good for insurances that want to prevent those costs down the line too
0 · Reply
Furderber
Furderber Feb. 20 at 4:24 PM
$EDAP SCOTUS decision may benefit EDAP eliminating tariffs. There are many positive developments for HIFU in US and ROW, and tranches minimize the risk of dilution. Updates on pipeline should be catalysts to $10 imho. Do your own DD.
0 · Reply
Georges8792
Georges8792 Feb. 20 at 7:59 AM
$EDAP https://www.linkedin.com/posts/cancer-prostatecancer-urology-ugcPost-7430276178839519232-Foxd?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
finedge
finedge Feb. 18 at 5:07 PM
$EDAP snapped up a few 😀
0 · Reply
finedge
finedge Feb. 18 at 3:41 PM
$EDAP nice entry point..
0 · Reply
ShadedFlicker
ShadedFlicker Feb. 18 at 8:06 AM
$EDAP EDAP TMS provides focused ultrasound for prostate cancer, facing surgeon training and reimbursement challenges [citation:historical].
0 · Reply
finedge
finedge Feb. 15 at 6:45 PM
$EDAP remarkable upcoming week. Focal Units sold, watch for HMO calibrating towards a proactive stance. Let’s go!
0 · Reply
Latest News on EDAP
EDAP Announces Appointment of David Horn to Board of Directors

Feb 12, 2026, 7:30 AM EST - 11 days ago

EDAP Announces Appointment of David Horn to Board of Directors

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

Jan 12, 2026, 7:30 AM EST - 6 weeks ago

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU

Nov 20, 2025, 7:30 AM EST - 3 months ago

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 7:00 AM EST - 3 months ago

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

EDAP TMS S.A. (EDAP) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:26 PM EST - 3 months ago

EDAP TMS S.A. (EDAP) Q3 2025 Earnings Call Transcript

EDAP Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 7:30 AM EST - 3 months ago

EDAP Reports Third Quarter 2025 Financial Results

EDAP to Present at Jefferies Global Healthcare Conference in London

Nov 4, 2025, 7:00 AM EST - 3 months ago

EDAP to Present at Jefferies Global Healthcare Conference in London

EDAP to Participate in the UBS Global Healthcare Conference

Oct 27, 2025, 7:00 AM EDT - 4 months ago

EDAP to Participate in the UBS Global Healthcare Conference

EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025

Oct 23, 2025, 7:00 AM EDT - 4 months ago

EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025

EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU

Oct 20, 2025, 8:30 AM EDT - 4 months ago

EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU

Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option

Sep 30, 2025, 7:00 AM EDT - 5 months ago

Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option

Focal One® HIFU Receives Prestigious Innovation Award

Sep 16, 2025, 7:00 AM EDT - 5 months ago

Focal One® HIFU Receives Prestigious Innovation Award

EDAP Receives HIFU Reimbursement for Prostate Cancer in France

Sep 8, 2025, 7:00 AM EDT - 6 months ago

EDAP Receives HIFU Reimbursement for Prostate Cancer in France

EDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call Transcript

Aug 28, 2025, 12:25 PM EDT - 6 months ago

EDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call Transcript

EDAP Reports Strong Second Quarter 2025 HIFU Results

Aug 28, 2025, 7:00 AM EDT - 6 months ago

EDAP Reports Strong Second Quarter 2025 HIFU Results

EDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic Expansion

Aug 26, 2025, 7:00 AM EDT - 6 months ago

EDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic Expansion

EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 25, 2025, 7:00 AM EDT - 6 months ago

EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025

Aug 7, 2025, 7:00 AM EDT - 7 months ago

EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025

EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status

Jul 1, 2025, 7:00 AM EDT - 8 months ago

EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status

EDAP to Present at the Jefferies Global Healthcare Conference

May 27, 2025, 7:00 AM EDT - 9 months ago

EDAP to Present at the Jefferies Global Healthcare Conference

EDAP TMS S.A. (EDAP) Q1 2025 Earnings Call Transcript

May 15, 2025, 10:08 AM EDT - 10 months ago

EDAP TMS S.A. (EDAP) Q1 2025 Earnings Call Transcript

EDAP Reports First Quarter 2025 Financial Results

May 15, 2025, 7:00 AM EDT - 10 months ago

EDAP Reports First Quarter 2025 Financial Results

EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025

May 1, 2025, 7:00 AM EDT - 10 months ago

EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025

EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

Apr 29, 2025, 7:00 AM EDT - 10 months ago

EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Apr 24, 2025, 7:00 AM EDT - 10 months ago

EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Apr 22, 2025, 7:00 AM EDT - 10 months ago

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 11:56 AM EDT - 11 months ago

EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

Mar 27, 2025, 7:10 AM EDT - 11 months ago

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Mar 6, 2025, 7:00 AM EST - 1 year ago

EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

EDAP Appoints Glen French to Board of Directors

Mar 3, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Glen French to Board of Directors

LUNG

Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

Feb 6, 2025, 8:00 AM EST - 1 year ago

Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

Jan 13, 2025, 7:00 AM EST - 1 year ago

EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

EDAP Appoints Joshua H. Levine to Board of Directors

Jan 10, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Joshua H. Levine to Board of Directors

EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

Jan 8, 2025, 7:00 AM EST - 1 year ago

EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer

Dec 4, 2024, 9:10 AM EST - 1 year ago

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer

EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis

Nov 19, 2024, 8:00 AM EST - 1 year ago

EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis

EDAP TMS S.A. (EDAP) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 9:16 PM EST - 1 year ago

EDAP TMS S.A. (EDAP) Q3 2024 Earnings Call Transcript

EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024

Oct 24, 2024, 8:00 AM EDT - 1 year ago

EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024

EDAP and Avenda Health Launch World's First AI-Assisted Focal One® Robotic HIFU Procedures

Sep 19, 2024, 8:00 AM EDT - 1 year ago

EDAP and Avenda Health Launch World's First AI-Assisted Focal One® Robotic HIFU Procedures

EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 29, 2024, 8:00 AM EDT - 1 year ago

EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

EDAP TMS S.A. (EDAP) Q2 2024 Earnings Call Transcript

Aug 28, 2024, 11:30 AM EDT - 1 year ago

EDAP TMS S.A. (EDAP) Q2 2024 Earnings Call Transcript

EDAP Reports Second Quarter 2024 Financial Results

Aug 28, 2024, 7:00 AM EDT - 1 year ago

EDAP Reports Second Quarter 2024 Financial Results

EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024

Aug 7, 2024, 7:00 AM EDT - 1 year ago

EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis

Jul 19, 2024, 4:15 PM EDT - 1 year ago

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis

EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations

Jun 3, 2024, 8:00 AM EDT - 1 year ago

EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations

EDAP TMS (EDAP) Q1 2024 Earnings Call Transcript

May 16, 2024, 1:59 PM EDT - 1 year ago

EDAP TMS (EDAP) Q1 2024 Earnings Call Transcript

EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting

May 6, 2024, 8:00 AM EDT - 1 year ago

EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

May 2, 2024, 8:00 AM EDT - 1 year ago

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

Apr 23, 2024, 8:00 AM EDT - 1 year ago

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

EDAP TMS (EDAP) Q4 2023 Earnings Call Transcript

Mar 27, 2024, 11:32 AM EDT - 2 years ago

EDAP TMS (EDAP) Q4 2023 Earnings Call Transcript

finedge
finedge Feb. 23 at 3:28 PM
$EDAP Financial reporting has factored in 10 percent tariff prior and buyers have paid the additional cost. Sales continue to pace well and will result in the future earnings. Stay strong to the long term and as an opinionated guidance Hold and Buy for a strengthened inflection point targeted record highs. There is an HMO purchase in the horizon. Let’s go!
0 · Reply
finedge
finedge Feb. 23 at 2:54 PM
$EDAP snapped up at 4.40
0 · Reply
Georges8792
Georges8792 Feb. 23 at 7:10 AM
$EDAP https://www.linkedin.com/posts/nirav-bhatt-76b7b521_endometriosis-hifu-focalone-activity-7430864360937291776-HqGV?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
mikegrand
mikegrand Feb. 23 at 3:36 AM
$EDAP https://youtu.be/DObcQVY4s5w?si=LTlNMNzzvR_d1t4l Interesting discussion in focal therapy, he mentions all the ongoing trials with HIFU and mentions the HIFUSA trial. I mentioned this trial awhile ago cause I was wanting an update and it seems it ends in June of this year and the preliminary results look good as it shows people that have HIFU early on instead of active surveillance have a 50% better chance of avoiding radical treatments down the line while still maintaining QoL That would be big if focal therapy takes place of active surveillance as a first line measure against most early cancers if you can avoid radical treatments downstream and would look good for insurances that want to prevent those costs down the line too
0 · Reply
Furderber
Furderber Feb. 20 at 4:24 PM
$EDAP SCOTUS decision may benefit EDAP eliminating tariffs. There are many positive developments for HIFU in US and ROW, and tranches minimize the risk of dilution. Updates on pipeline should be catalysts to $10 imho. Do your own DD.
0 · Reply
Georges8792
Georges8792 Feb. 20 at 7:59 AM
$EDAP https://www.linkedin.com/posts/cancer-prostatecancer-urology-ugcPost-7430276178839519232-Foxd?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
finedge
finedge Feb. 18 at 5:07 PM
$EDAP snapped up a few 😀
0 · Reply
finedge
finedge Feb. 18 at 3:41 PM
$EDAP nice entry point..
0 · Reply
ShadedFlicker
ShadedFlicker Feb. 18 at 8:06 AM
$EDAP EDAP TMS provides focused ultrasound for prostate cancer, facing surgeon training and reimbursement challenges [citation:historical].
0 · Reply
finedge
finedge Feb. 15 at 6:45 PM
$EDAP remarkable upcoming week. Focal Units sold, watch for HMO calibrating towards a proactive stance. Let’s go!
0 · Reply
Georges8792
Georges8792 Feb. 13 at 10:15 AM
$EDAP https://www.linkedin.com/posts/hugoembert_medtech-hiring-cancer-activity-7427870187317612544-B5yB?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
1 · Reply
finedge
finedge Feb. 12 at 8:21 PM
$EDAP David Horn is known and solid towards future consolidation. Very excited, let’s go!
1 · Reply
Furderber
Furderber Feb. 12 at 2:24 PM
$EDAP Horn moves up to the Board. Came from Morgan Stanley. Notice Morgan Stanley has accumulated ~3M shares since he was onboarded. French out.
0 · Reply
Georges8792
Georges8792 Feb. 12 at 6:20 AM
$EDAP https://www.linkedin.com/posts/focal-one_usicon2026-cancer-prostatecancer-ugcPost-7427412581348306944-l50H?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
topstockalerts
topstockalerts Feb. 11 at 4:44 PM
$EDAP Looks like it wants higher prices. Buyers keep stepping in. This trend is still alive 📈.
0 · Reply
JBird17
JBird17 Feb. 11 at 2:47 PM
$EDAP @mikegrand NCT06211933 for pancreatic tumor treatment changed in January from ‘Recruiting’ to ‘Active, not recruiting’. Noticed you asking about trials on yahoo. If you go to clinical trials. Gov you can search HIFU with France as the location and you can see everything being worked on or completed.
0 · Reply
Furderber
Furderber Feb. 10 at 6:47 PM
$EDAP Good volume today, 155k shares traded by around 1:43pm. I am pretty sure some who bought below $2 are reducing their exposure, but price is holding up. My target price is $15/share as it has been over the last 7 years....
0 · Reply
Georges8792
Georges8792 Feb. 10 at 4:56 PM
$EDAP https://www.linkedin.com/posts/jenny-robeson-3b0b024_high-intensity-ultrasound-treatment-activity-7427012047076470785-xf9C?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Feb. 9 at 4:26 PM
$EDAP https://www.linkedin.com/posts/satish-kumar-60a29026b_prostatecancer-robotichifu-focaltherapy-ugcPost-7426643442933460992--IRw?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
finedge
finedge Feb. 9 at 3:03 PM
$EDAP margin capacity will increase at 30 day range at 5. Instituional leaps likely, let’s go as insiders hold for long term as not to drive share value down. Retail holders rewarded at 7 plus
1 · Reply
Georges8792
Georges8792 Feb. 8 at 6:12 PM
$EDAP https://www.linkedin.com/posts/dr-kalyan-kumar-thallapudi-7937971b5_oncology-aiinhealthcare-medicaltechnology-activity-7426286531855781888-ol78?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
mikegrand
mikegrand Feb. 7 at 4:04 AM
$EDAP https://www.sciencedirect.com/science/article/abs/pii/S1078143926000037?dgcid=author So I found this study that shows the majority of the population doesn’t know that focal therapy is an option for pCa and that the r more educated/wealthy you are the more you know about the treatment option. There needs to be a focus on informing communities on this option, I ‘d say it’s the company’s job to do that but we need equal help from the hospitals that supply the option as they are beacons for the community.
0 · Reply